The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient ...

The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

Pharma stocks plummeted on 17 June, following reports that US President Donald Trump indicated that pharmaceutical tariffs ...

Israel-Iran conflict enters fifth day: Iranian ambassador tells UN its strikes are ‘self-defence’ 6 signs of Vitamin B12 deficiency and how to address it in one month Man who lost 124 kgs shares how ...

Sun Pharma shares plunged over 2%, extending losses for the second consecutive session. Notably, it is currently the top ...

Market expert Neeraj Dewan is optimistic about the defence sector's long-term growth, highlighting budget allocations and ...

During Tuesday’s trading session, shares of a global biopharmaceutical company engaged in the manufacturing of biotechnology products and research services are in focus, after the company launched a ...

Bengaluru-based Biocon Ltd. closes the window to list its arm, Biocon Biologics Ltd., as it raises Rs 4,500 crore to provide ...

Shares of Biocon Ltd., surged 1.3% on Tuesday after the company's board of directors approved the floor price for the share ...

Biocon informed that its board has approved the opening of the issue of qualified institutional placement (QIP) of equity shares with the floor price of Rs 340.20 per equity share.

Biocon shares will be in focus of stock market investors on Tuesday, 17 June 2025, after the company's board of directors ...

The report highlights the top five sectors drawing the most capital: Consumer Products & Brands led with a 9.55% share, ...